Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lisuride in dystonia.

N P Quinn, A E Lang, M P Sheehy

    Neurology
    |May 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Lisuride hydrogen maleate showed potential in treating dystonia, with seven of eight improved patients confirmed by placebo. However, its effectiveness varied, and it did not benefit patients with brain lesions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Refining a mouse model of progressive supranuclear palsy through inoculation of human post-mortem brain-derived tau.

    BMC research notes·2026
    Same author

    Opinions and clinical practices related to diagnosing and managing functional (psychogenic) movement disorders: changes in the last decade.

    European journal of neurology·2020
    Same author

    Tremor with congenital mirror movements: evidence of involvement of the primary motor cortex in tremor.

    European journal of neurology·2019
    Same author

    Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

    Movement disorders : official journal of the Movement Disorder Society·2017
    Same author

    Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells.

    Scientific reports·2017
    Same author

    Neurologic diagnostic criteria for functional neurologic disorders.

    Handbook of clinical neurology·2016
    Same journal

    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

    Neurology·2026
    Same journal

    Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

    Neurology·2026
    Same journal

    Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

    Neurology·2026
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    See all related articles

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Dystonia is a movement disorder characterized by involuntary muscle contractions.
    • Current treatments for dystonia have limitations, necessitating exploration of new therapeutic agents.

    Purpose of the Study:

    • To evaluate the efficacy of lisuride hydrogen maleate in patients with various forms of dystonia.
    • To assess the safety and tolerability of lisuride hydrogen maleate in this patient population.

    Main Methods:

    • A total of 42 subjects with different types of dystonia received oral lisuride hydrogen maleate (0.4 to 5 mg/d).
    • Double-blind placebo substitution was used to confirm treatment response in patients who showed improvement.
    • Patients with suspected structural brain lesions were excluded from response analysis.

    Related Experiment Videos

    Main Results:

    • Seven out of eight patients who initially improved experienced confirmed benefits via double-blind placebo substitution.
    • Improved patients included those with segmental dystonia, myoclonic dystonia, spasmodic torticollis, cranial dystonia, and tardive dystonia.
    • No patients with suspected structural brain lesions showed improvement, and no consistent response pattern was observed across idiopathic dystonia types.

    Conclusions:

    • Lisuride hydrogen maleate demonstrated efficacy in a subset of dystonia patients, with benefits confirmed by objective measures.
    • The drug's effectiveness appears variable, suggesting potential patient-specific responses or underlying disease heterogeneity.
    • Further research is warranted to identify predictors of response and optimize lisuride use in dystonia management.